* Sotera Health Co SHC.OQ SHC.O is expected to show a
rise in
quarterly revenue when it reports results on November 2.
* The Broadview Heights Ohio-based company is expected to
report
a 9.7% increase in revenue to $248.204 million from $226.16
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Sotera Health Co is
for
earnings of 22 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 6
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Sotera
Health Co
is $9, above its last closing price of $6.92.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 0.24 0.24 0.27 Beat 11.3
Mar. 31 2022 0.19 0.19 0.22 Beat 13.6
Dec. 31 2021 0.22 0.22 0.23 Beat 3.8
Sep. 30 2021 0.20 0.20 0.21 Beat 2.7
Jun. 0.21 0.21 0.26 Beat 24.7
30 2021
Mar. 31 2021 0.16 0.16 0.18 Beat 11.6
Dec. 31 2020 0.07 0.07 0.09 Beat 29.7
This summary was machine generated October 31 at 16:43 GMT. All
figures in US dollars unless otherwise stated